Q1 Earnings Estimate for Cibus Issued By HC Wainwright

Cibus, Inc. (NASDAQ:CBUS) – Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Cibus in a report issued on Friday, March 21st. HC Wainwright analyst A. Dayal forecasts that the company will post earnings per share of ($0.66) for the quarter. HC Wainwright has a “Buy” rating and a $25.00 price target on the stock. The consensus estimate for Cibus’ current full-year earnings is ($2.96) per share. HC Wainwright also issued estimates for Cibus’ Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.

Cibus (NASDAQ:CBUS) last announced its quarterly earnings data on Thursday, March 20th. The company reported ($0.87) earnings per share for the quarter, missing the consensus estimate of ($0.68) by ($0.19). The firm had revenue of $1.21 million for the quarter, compared to analyst estimates of $1.13 million. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%.

Separately, Canaccord Genuity Group dropped their price objective on shares of Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Wednesday, January 22nd.

Cibus Price Performance

Shares of CBUS stock opened at $2.09 on Monday. Cibus has a one year low of $1.80 and a one year high of $23.18. The stock has a fifty day moving average price of $2.32 and a 200 day moving average price of $3.28. The stock has a market cap of $55.29 million, a P/E ratio of -0.09 and a beta of 2.04.

Hedge Funds Weigh In On Cibus

A number of hedge funds have recently modified their holdings of the stock. IFP Advisors Inc acquired a new stake in Cibus in the 4th quarter valued at $36,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Cibus in the 3rd quarter valued at $44,000. Virtu Financial LLC acquired a new stake in shares of Cibus in the 3rd quarter valued at $48,000. Sei Investments Co. bought a new stake in shares of Cibus in the 4th quarter worth about $49,000. Finally, HighTower Advisors LLC increased its position in shares of Cibus by 20.6% during the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock worth $52,000 after purchasing an additional 2,750 shares in the last quarter. 33.81% of the stock is owned by institutional investors and hedge funds.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.